Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sperling

Showing results (241-250 of 441) with videos related to

Pageof 45
Sort By:
Journal of Cardiopulmonary Rehabilitation and Prevention|November 1, 2016
Multicenter Study of Temporal Trends in the Achievement of Atherosclerotic Cardiovascular Disease Risk Factor Goals During Cardiac RehabilitationNeil F Gordon, Richard D Salmon, Laurence S Sperling, et al.
European Journal of Preventive Cardiology|November 28, 2024
Traditional Risk Factors, Optimal Cardiovascular Health, and Elevated Lipoprotein(a)Alexander C Razavi, Mikaila P Reyes, John T Wilkins, et al.
The New England Journal of Medicine|March 26, 1992
A survey of zidovudine use in pregnant women with human immunodeficiency virus infectionR S Sperling, P Stratton, M J O'Sullivan, et al.
American Journal of Preventive Cardiology|April 29, 2024
Temporal trends and racial/ethnic- and sex-differences in LDL cholesterol control among US adults with self-reported atherosclerotic cardiovascular diseaseDanh Q Nguyen, Neil Keshvani, Alvin Chandra, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: end-of-study analysis of a Phase III randomized trialMark H Einstein, Peter Takacs, Archana Chatterjee, et al.
Lipids in Health and Disease|March 5, 2026
Real-world effectiveness and cardiovascular outcomes of PCSK9 inhibitor therapy: a prospective registry studyJan Kafol, Zlatko Fras, Marko Novakovic, et al.
The Journal of Infectious Diseases|August 11, 1998
Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 TeamM Mirochnick, T Fenton, P Gagnier, et al.
Expert Opinion on Drug Safety|October 31, 2023
A safety review of recently approved and emerging drugs for patients with relapsed or refractory multiple myelomaShonali Midha, Monique A Hartley-Brown, Clifton C Mo, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 2, 2001
Prediction of safe duration of hypothermic circulatory arrest by near-infrared spectroscopyT Sakamoto, S Hatsuoka, U A Stock, et al.
Current Problems in Cardiology|December 16, 2023
Trends in sleep apnea and heart failure related mortality in the United States from 1999 to 2019Aleezay Asghar, Khawaja M Talha, Eisha Waqar, et al.
Pageof 45

Showing results (241-250 of 441) with videos related to

Sort By:
Pageof 45
Journal of Cardiopulmonary Rehabilitation and Prevention|November 1, 2016
Multicenter Study of Temporal Trends in the Achievement of Atherosclerotic Cardiovascular Disease Risk Factor Goals During Cardiac RehabilitationNeil F Gordon, Richard D Salmon, Laurence S Sperling, et al.
European Journal of Preventive Cardiology|November 28, 2024
Traditional Risk Factors, Optimal Cardiovascular Health, and Elevated Lipoprotein(a)Alexander C Razavi, Mikaila P Reyes, John T Wilkins, et al.
The New England Journal of Medicine|March 26, 1992
A survey of zidovudine use in pregnant women with human immunodeficiency virus infectionR S Sperling, P Stratton, M J O'Sullivan, et al.
American Journal of Preventive Cardiology|April 29, 2024
Temporal trends and racial/ethnic- and sex-differences in LDL cholesterol control among US adults with self-reported atherosclerotic cardiovascular diseaseDanh Q Nguyen, Neil Keshvani, Alvin Chandra, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: end-of-study analysis of a Phase III randomized trialMark H Einstein, Peter Takacs, Archana Chatterjee, et al.
Lipids in Health and Disease|March 5, 2026
Real-world effectiveness and cardiovascular outcomes of PCSK9 inhibitor therapy: a prospective registry studyJan Kafol, Zlatko Fras, Marko Novakovic, et al.
The Journal of Infectious Diseases|August 11, 1998
Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 TeamM Mirochnick, T Fenton, P Gagnier, et al.
Expert Opinion on Drug Safety|October 31, 2023
A safety review of recently approved and emerging drugs for patients with relapsed or refractory multiple myelomaShonali Midha, Monique A Hartley-Brown, Clifton C Mo, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 2, 2001
Prediction of safe duration of hypothermic circulatory arrest by near-infrared spectroscopyT Sakamoto, S Hatsuoka, U A Stock, et al.
Current Problems in Cardiology|December 16, 2023
Trends in sleep apnea and heart failure related mortality in the United States from 1999 to 2019Aleezay Asghar, Khawaja M Talha, Eisha Waqar, et al.
Pageof 45